Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Group Sign-On Letter Supporting the VITAL Act
-
ACMG Letter of Support for the Expanded Genetic Screening Act
-
ACMG Letter to Congress Concerning the Verifying Accurate Leading-edge IVCT Development (VALID) Act
-
ACMG Comments to CMS about Proposed Changes to the PFS for CY 2021
-
Group Sign-on Letter to HHS Supporting Clarification of LDT Regulatory Process
-
ACMG Comments to Congress Concerning the Verifying Accurate Leading-edge IVCT Development (VALID) Act Discussion Draft
-
ACMG Letter to Congress Concerning the FDA Technical Assistance for the Diagnostic Accuracy and Innovation Act (DAIA)
-
Group Sign-on Letter to Congress Concerning the Diagnostic Accuracy and Innovation Act (DAIA)
-
Group Sign-on Letter to Congress Opposing the Preserving Employee Wellness Programs Act (HR 1313)
-
ACMG/AMP/IDSA Joint Congressional Briefing on LDTs